A Statistical Procedure to Selectively Detect Metabolite Signals in LC-MS Data Based on Using Variable Isotope Ratios  by Lin, Lung-Cheng et al.
A Statistical Procedure to Selectively Detect
Metabolite Signals in LC-MS Data Based on
Using Variable Isotope Ratios
Lung-Cheng Lin,a Hsin-Yi Wu,a Vincent Shin-Mu Tseng,b
Lien-Chin Chen,b Yu-Chen Chang,a and Pao-Chi Liaoa,c
a Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung
University, Tainan, Taiwan
b Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan,
Taiwan
c Sustainable Environment Research Center, National Cheng Kung University, University Road, Tainan,
Taiwan
The tracing of metabolite signals in LC-MS data using stable isotope-labeled compounds has
been described in the literature. However, the filtering efficiency and confidence when mining
metabolite signals in complex LC-MS datasets can be improved. Here, we propose an
additional statistical procedure to increase the compound-derived signal mining efficiency.
This method also provides a highly confident approach to screen out metabolite signals
because the correlation of varying concentration ratios of native/stable isotope-labeled
compounds and their instrumental response ratio is used. An in-house computational program
[signal mining algorithm with isotope tracing (SMAIT)] was developed to perform the
statistical procedure. To illustrate the SMAIT concept and its effectiveness for mining
metabolite signals in LC-MS data, the plasticizer, di-(2-ethylhexyl) phthalate (DEHP), was
used as an example. The statistical procedure effectively filtered 15 probable metabolite signals
from 3617 peaks in the LC-MS data. These probable metabolite signals were considered
structurally related to DEHP. Results obtained here suggest that the statistical procedure could
be used to confidently facilitate the detection of probable metabolites from a compound-
derived precursor presented in a complex LC-MS dataset. (J Am Soc Mass Spectrom 2010, 21,
232–241) © 2010 American Society for Mass SpectrometryStable isotope-labeled compounds coupled withliquid chromatography mass spectrometry (LC-MS) have been applied to mine metabolite signals.
One strategy to mine MS data for metabolite signals
uses the isotope cluster that is formed after treating test
subjects with an equal mixture of native and isotope-
labeled compounds [1–3]. In mineral metabolism re-
search, the stable isotope ratio (1:1) from spiked native
and isotope-labeled compounds has been used for me-
tabolite signal detection. The equal response signatures
of signal doublets were traced [4]. A strategy using the
stable isotope-labeled tracing concept has been devel-
oped to detect reactive metabolites, such as glutathione-
conjugated metabolites [5].
Another report has demonstrated that equal amounts
of native and stable isotope-labeled compounds can be
used to detect untargeted metabolite signals with partic-
ular isotopic ratios in LC-MS data, where this work also
demonstrated the use of a computational program, DoGEX,
to facilitate the signal mining process [6]. The program
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stable isotope ratio and mass difference after data align-
ment, noise removal, baseline correction, peak detection,
and spectral filtering processes. Additionally, the program
requires a user-defined isotopic ratio of native to isotope-
labeled signal responses to define metabolite signals.
However, the isotopic ratios of metabolite signals from
equal amounts of spiked native and isotope-labeled com-
pounds are not always closed to 1 because of the influ-
ences from analytical variations of sample preparation,
instrumental analysis, and matrix interference. This is
especially true when signal doublet responses are low [7].
Setting acceptable tolerance for wanted ratios is still em-
pirical, which results in the challenges while tracing one
specific ratio [8].
We propose, herein, an additional statistical proce-
dure to assist the conventional isotope-labeling method.
We believe that coupling a stable isotope ratio with the
statistical procedure could enhance the efficiency and
confidence of mining metabolite signals in complex
LC-MS data. We used varying isotope concentration
ratios and mass measurements to trace the signals of
metabolites, which were generated from in vitro incuba-
tion, in LC-MS data. Varying isotope concentration ratios
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tive samples have been proposed to statistically correlate
to their signal responses, which provided higher confi-
dence than the conventional isotope-labeling method. An
in-house computational program, comprising a signal
mining algorithm with isotope tracing (SMAIT), was
developed to perform the statistical procedure.
Di-(2-ethylhexyl) phthalate (DEHP) with a wide range
of metabolites, including mono-(2-ethyl-hexyl) phthalate
(MEHP), mono-(2-ethyl-hydroxyhexyl) phthalates (OH-
MEHPs), mono-(2-ethyl-oxohexyl) phthalates (oxo-MEHPs),
and mono-(2-ethyl-carboxypentyl) phthalates (cx-MEPPs),
has been reported [9–11]. To illustrate the effectiveness of the
proposed procedure for detecting metabolite signals within
LC-MS data, DEHP was used as a model compound.
Experimental
Materials
DEHP, D4-DEHP, MEHP, 5OH-MEHP, and 5oxo-
MEHP were purchased from Cambridge Isotope Labo-
ratories (Andover, MA, USA). Glucose 6-phosphate,
glucose 6-phosphate dehydrogenase, -nicotinamide
adenine dinucleotide phosphate (NADP), formic acid,
acetic acid, and buffer salts were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Methanol (HPLC grade)
was purchased from Merck (Darmstadt, Germany).
Deionized water was acquired using a Millipore system
(Milford, MA, USA).
Rat Liver Enzyme Preparation and Incubation
For generating metabolites from a parent compound,
the simple and commonly used method of in vitro liver
enzyme incubation was adopted [3, 6]. Liver tissue (0.5
g) from one healthy male Wistar rat, without any drug
treatment, was added to 3 mL ice buffer. The liver tissue
was homogenized, sonicated, and centrifuged at 9000
g for 15 min (4 °C). The supernatant containing proteins
was collected and kept at 80 °C before use. The
protein concentration was determined using a Bradford
assay [12].
In vitro liver enzyme incubation was performed to
generate DEHP metabolites. The incubation mixture
contained DEHP, D4-DEHP, 1.3 mM NADP, 3.3 mM
MgCl2, 3.3 mM glucose 6-phosphate, 0.4 U/mL glucose
6-phosphate dehydrogenase, and 1.6 mg/mL enzyme
protein in phosphate buffer (100 mM, pH  7.4). The
total concentration of spiked DEHP and D4-DEHP in a
mixture sample was 15 M. For illustrating the SMAIT
strategy using varying isotope concentration ratios, five
samples were incubated. These had concentration ratios
of DEHP to D4-DEHP of 3:7, 4:6, 5:5, 6:4, and 7:3. The
metabolic reaction was initiated by adding NADP.
Subsequently, the spiked sample was incubated at 37 °C
for 1 h. Acetic acid (20%, 100 L) was added to
terminate the reaction.Sample Preparation
The incubated sample was passed through a 0.2 m
PVDF membrane filter (MSF-3; Advantec MFS, Inc.,
Pleasanton, CA, USA), before off-line solid-phase ex-
traction (SPE). This C18 cartridge (Sigma-Aldrich, St.
Louis, MO, USA) was pre-conditioned with MeOH
followed by H2O. After loading the filtered sample, the
sample in the cartridge was washed with 2 mL H2O and
eluted with 2 mL MeOH. The eluted sample was dried
under nitrogen. Subsequently, 100 L of 20% acetic acid
and 400 L of H2O were added. The sample was stored at
4 °C until LC-MS analysis was performed.
LC-MS Analysis
Liquid chromatography was carried out on a HPLC
system equipped with a PE series 200 autosampler
(Perkin Elmer, Norfolk, CT, USA) and a PE series 200
binary pump (Perkin Elmer). MS analyses were per-
formed on a quadrupole-time of flight (Q-TOF) mass
spectrometer (QSTAR Pulsar; Applied Biosystems/
MDS SCIEX, Foster City, CA, USA). This instrument
was equipped with a TurboIonSpray ionization source.
Chromatography was achieved using a 2.0  55 mm
C18 column (3-m particle size; Merck, Darmstadt,
Germany). The chromatographic loading and elution
solvents were H2O (0.1% formic acid) and MeOH (0.1%
formic acid), respectively. The flow rate for LC gradient
analysis was 300 L/min. The incubated sample was
loaded onto the C18 column by running solvent (H2O
with 0.1% formic acid) through it for 5 min. At 5 min,
the gradient elution was started with the gradient at
3.3%/min from 0 to 100% elution solvent for 30 min.
After the gradient elution step, the column was washed
with elution solvent for 20 min. Finally, the column was
re-equilibrated for 1 min by loading solvent before the
next sample injection.
For metabolite ionization via ESI deprotonation, the
negative ionization mode was used with an ion spray
voltage of 4500 V. Nitrogen was used as the curtain,
nebulizer, and turbo gas (400 °C), with settings of 20, 20,
and 60 psi, respectively. Full-scan mass spectra were
acquired within the mass range ofm/z 80–600. Full-scan
operating parameters in the TOF-MS mode were as
follows: accumulation time  1 s, mirror voltage 
0.990 kV, plate voltage  0.339 kV, grid voltage  0.415
kV, liner voltage  15 V, and offset voltage  15 V
with resolution at a minimum of 7000. All samples were
analyzed using identical instrumental conditions.
Peak Defining in LC-MS Spectra
A commercially available program, Metabolomics Ex-
port Script (MES, ver. 1.1.2.0; Applied Biosystems), was
used to analyze LC-MS signals and export a raw peak
list, which contained m/z, retention time (RT), and signal
response information. MES set parameters for each
LC-MS spectrumwere as follows: subtraction offset 150
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old  10; minimum spectral peak width  1 ppm;
minimum RT peak width  2 scans; and maximum RT
peak width  100 scans.
MS/MS Analysis
To confirm the presence of metabolites, the Q-TOF
product ion scan was used to obtain product ion
profiles of metabolite signals via collision-induced dis-
sociation (CID). Metabolite signals were confirmed by
comparing their product ion profiles with those of
commercial standards.
LC and TurboIonSpray source conditions for
MS/MS analysis were set to be identical to those from
the TOF-MS mode. Precursor ion selection in the qua-
druple (Q1) was set at unit resolution. The collision
energy (CE) was optimized to obtain the highest MEHP
signal intensity and was set at 20 eV for the product
ion scan of all metabolites. Accumulation time in the
TOF analyzer for product ion collection was set at 1 s.
Native and isotope-labeled metabolite signals were
both analyzed to obtain their product ion profiles.
Results and Discussion
General Summary of the Statistical Procedure
In the proposed statistical procedure, varying isotope
concentration ratios of native to stable isotope-labeledFigure 1. Analytical approaccompounds among five mixtures are used as tracers to
filter out probable metabolite signals. The procedure
uses the assumption that the native to stable labeled-
isotope concentration ratios of metabolite signals, the
isotopic pairs (IPs), correlate to their spiked varying
concentration ratios. As shown in Figure 1, five mix-
tures with different isotope concentration ratios were
incubated with liver enzymes to generate metabolites.
The incubation mixtures were desalted and the metab-
olites concentrated by SPE, which was followed by
LC-Q-TOF analysis. LC-MS data from the five mixtures
were subjected to the MES program to generate raw
peak lists. After the peak stratification step, an in-house
computational algorithm (SMAIT) was used to extract
probable metabolite signals from the complex LC-MS
data. Probable metabolite signals were confirmed by
comparing their product ion profiles with those of
commercial standards.
SMAIT Computer Program Algorithm
Recently, a computational program was developed to
provide an efficient tool for extracting phosphopeptide
signals from complex LC-MS data [13]. This program
uses the mass difference between phosphopeptide and
dephosphopeptide signals to filter out the phosphopep-
tide signals. Using a similar concept, we developed the
SMAIT algorithm. This algorithm mines metabolite
signals by not only measuring the specific mass shifth of the SMAIT strategy.
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calculating the correlation between the varying concen-
tration ratios and the responses. The proposed algo-
rithm contains three steps, including peak stratification,
isotopic pair finding, and IP response ratio (IPRR)
correlation analysis.
Peak Stratification
LC-MS results were processed by the MES program to
generate raw peak lists. The purpose of peak stratifica-
tion is to consolidate m/z values in the raw peak list to
a specific precision, as defined by the user based on
instrumental conditions. Initially for LC-MS data, in the
m/z dimension, a scan range (Mr) of 80–600 is divided
into n parts (Mp) with a user-defined width (K). As
shown in eq 1, a peak with M m/z is stratified into its ith
part (Mpi). If eq 1 has been fulfilled, the median of Mp
in the m/z dimension is used to represent the m/z value





where i  1 to n and n  (Mr)/K.
The user-defined width (K) is determined based on
the m/z value variation of peaks among analytical runs.
According to data from our application experiment, as
described below using DEHP incubation samples, the K
value was set to 0.2.
After stratification of the m/z dimension, peaks in a
particular Mp with similar retention times (RTs) are
classified as being in one cluster (C). Thus, the re-
sponses of these peaks are consolidated into one peak.
To define the RT cluster in a particular Mp, the peaks
are sorted by their RTs, and then eq 2 and 3 must be
fulfilled. In these equations, Rr is a user-defined range
of retention time for different chromatographic con-
ditions. At each given Mp, a newly defined peak was
assigned and its response and the RT are from the
response sum and RT average of all the peaks in
the same cluster. The difference of new peak RT and the
first peak of next cluster should be lower than Rr.
{peaki, peaki1, . . . peakn}Cj
RTcjRTpeak 1 of Cji Rr (2)
where i  1  n, j  1  n.
i is the peak number, j is the cluster number, and C
is a peak cluster defined as a new peak.
LC-MS dataset is put through the peak stratification
process separately to generate the stratified peak list.
According to the results from our application experi-
ment, as described below using DEHP incubation mix-
tures, the Rr was set to 0.5 min.Isotopic Pair Finding
The goal of this step is to discover the IPs of native and
labeled-isotope peak doublets in a stratified peak list
that have a mass shift (MZ) within a user-defined RT
difference (RT). Equation 4 describes the criteria for
defining IPs in LC-MS data. If the mass difference
between MZi and MZj of peaks Pi, and Pj, equals MZ,
and the difference of the RTs between two peaks is less
than RT, these two peaks are determined as an IP. In
this equation, RTpi and RTpj are the RTs of peaks with
a mass shift, respectively.
|RTpiRTpj| RT (3)
where i  1  n, j  1  n, k  1  n.
If eq 4 is fulfilled, the IP response ratio (IPRR) and
the average of their retention times are recorded for
subsequent IP correlation analysis. In the present study,
the MZ setting value was 4.0 and the RTs of IPs in
the LC-MS data were consistently smaller than 0.1 min.
IP Response Ratio (IPRR) Correlation Analysis
The goal of this step is to locate the IPs that give
response ratios that correlate with expected concentra-
tion ratios. It is assumed that the IPs with high correla-
tion coefficients have a higher probability of containing
probable metabolite signals. One challenge is that it
is common to observe an RT shift between different
analytical runs in chromatographic analyses. The RT
shift may cause a missing IP for a particular concentra-
tion ratio and increase the difficulty of metabolite signal
mining using the SMAIT strategy. To solve this prob-
lem, we utilized a user-defined sliding window (W) in
the RT dimension, instead of a peak alignment process.
Peaks of respective samples in the window (W) are
grouped to calculate their correlation coefficients. In the
RT dimension, sliding window scanning is based about
peaks in five LC-MS datasets to find out the IP combi-
nations and their corresponding R values. The SMAIT
program finally outputs a table containing m/z values,
retention times, response ratio, and IP correlation coef-
ficient. Based on data from the five incubation mixtures
of DEHP, RT shifts of the known peaks were always
less than 0.5 min. Therefore, the RT sliding window (W)
was set as 0.5 min for the current chromatographic
condition.
Illustration of the Statistical Procedure Using
DEHP and D4-DEHP
According to our data from the DEHP/D4-DEHP incu-
bation mixture, when only one concentration ratio (1:1)
was used, a total of 787 IPs having a 4-Da shift and
within 0.1 min of the RT range were found (data not
shown). To ensure that the known DEHP metabolites
(MEHP, OH-MEHPs, and oxo-MEHP) were all identi-
fied, a 30% response ratio allowance (1.0  0.3) was
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total number of qualified IPs was reduced from 787 to
108. Although the known DEHP metabolites were in-
cluded in these remaining 108 IPs, there are still many
qualified IPs that require further confirmation.
After LC-MS analyses and SMAIT program screen-
ing, the IPs, which contain probable metabolite signals,
were generated. To demonstrate the different filtering
efficiencies of different concentration mixtures, the
number of IPs recognized by SMAIT were plotted when
three, four, or five concentration mixtures were used.
As for three ratios, all combination generated 50  70
IPs containing 9  10 IPs (S/N  3). For example, if
ratios of 4:6, 5:5, and 6:4 were used, 55 IPs containing
10 IPs can be obtained. Sixty-six IPs containing 9 IPs
(S/N 3) were obtainedwhile using ratios of 5:5, 6:4, and
7:3 Another three isotope ratios, 3:7, 5:5, and 7:3,
showed 70 IPs containing 9 IPs (S/N  3). As for the
combination of using four ratios, 23  24 IPs containing
9 IPs were selected. A total of 23 IPs containing 9 IPs
(S/N  3) were obtained while using ratios of 4:6, 5:5,
6:4, and 7:3. For another case (3:7, 4:6, 5:5, and 6:4), result
showed 24 IPs containing 9 IPs (S/N  3). Here, ratios of
4:6, 5:5, and 6:4 were used as an example for three
concentration ratios, while 4:6, 5:5, 6:4, and 7:3 were the
example for four concentration ratios in Figure 2.
As shown in Figure 2, the correlation coefficient
values of qualified IPs greater than 0.9 were plotted
against the number of concentration ratios used to
generate the IPs. When three native to isotope-labeled
concentration ratios (4:6, 5:5, and 6:4) were used, a total
of 55 probable metabolite signals were identified. With
an increase in the number of concentration ratios to four
(4:6, 5:5, 6:4, and 7:3) the number of probable metabolite
Figure 2. IP results with high R values (0.9) in the three groups,
containing three, four, and five concentration ratios, after SMAIT
screening. IPs, containing probable metabolite signals, are further
confirmed as to whether they are known DEHP metabolites (black
diamonds) or are related but lack standard confirmation (gray
diamonds). When IPs at the 5:5 concentration ratio had small
signal responses (S/N 	 3), they were considered as suspicious
metabolite signals (open diamonds).signals was reduced to 23. The number of probable
metabolite signals was further reduced to 12 when five
concentration ratios were used.
Probable metabolite signals were further confirmed
as to whether they are known DEHP metabolites (de-
picted as black diamonds in Figure 2). When IPs
at the 5:5 concentration ratio had small signal re-
sponses (S/N 	 3), they were considered as suspicious
metabolite signals (open diamonds). Gray diamonds
indicate the S/Ns of IPs greater than 3, but without
reference material for a structural confirmation. There
were 55, 23, and 12 IPs, containing 10, 9, and 8 IPs
(S/N  3) related to DEHP metabolites, respectively.
These were within the groups with three, four, and five
concentration ratios, respectively. Results demonstrated
that the use of greater numbers of isotope concentration
ratios could efficiently decrease the number of suspi-
cious metabolites that are confirmed.
In summary, more than 3600 signals were found by
the MES program when a concentration ratio of 5:5 was
used (Figure 3a). Only 8 IPs fulfilled all of the user-
defined requirements, including R  0.90 and S/N  3
(Figure 3b), after SMAIT program screening using five
concentration ratios. The 8 IPs that contained probable
metabolite signals with high confidence were further
investigated.
The 8 IPs recognized by SMAIT as containing prob-
able metabolite signals are listed in Table 1. Extract ion
chromatograms (XICs) of the 8 IPs at a 5:5 concentration
ratio are shown in Figure 4a–g, with Figure 4c contain-
ing 2 sets of IPs. In all XICs of the IPs, the D4-labled
isotopic peaks were consistently eluted slightly earlier
than their native peaks. The RT differences were all less
than 5 s. Notice that Figure 4b (m/z 291.1/295.1), c (m/z
293.1/297.1), e (m/z 361.1/365.1), and g (m/z 409.1/
413.1) each contain more than one peak. However,
SMAIT reported them as having one IP for each chro-
matographic peak cluster. This was due to the peak
defining process in MES. The poorly separated peaks
were recognized as one peak in MES and therefore
reported as one signal. The resolution of each peak was
manually calculated and results are shown in Figure 4.
Based on the manual resolution calculation, these four
IPs were defined to contain more than one peak, each
with resolution greater than 0.75. After manual resolu-
tion calculation, 15 probable metabolite signals were
defined. The number of peaks within each IP, as rede-
fined with resolution  0.75, are listed in Table 1.
To confirm the chemical structures of probable me-
tabolites, the LC-MS/MS product ion profiles of all 15
probable metabolites were obtained and compared with
their commercially available standards. Tables 2 and 3
list the top four most intense product ions. Among the
previously reported DEHP metabolites [9–11], only
three metabolite standards were commercially available
(MEHP, 5OH-MEHP, and 5oxo-MEHP). These three
standards were used to confirm the chemical structures
of these three metabolites. As shown in Table 2, the
precursor ion of MEHP (m/z 277.1; RT 34.11 min) is a
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negative ionization mode. This generated product ions
at m/z 121.0509, 127.1334, 134.0591, and 233.1851. The
RT value, precursor ion mass, and product ion profile of
the SMAIT recognized signal (m/z 277.1) were similar to
those characteristics for the MEHP standard. This result
suggests that metabolite I is MEHP. Further evidence
for this was given by the product ion profile of metab-
olite Id (precursor ion m/z 281.1). The m/z 281.1 precur-
sor ion generated the following product ions: m/z
125.0757, 127.1331, 138.0855, and 237.1204. Compared
with the product ion profile of metabolite I, m/z
125.0757, 138.0855, and 237.1204 contained the D4-
labeled aromatic group and yielded a 4-Da shift.
Therefore, the probable metabolite signals of m/z
277.1 and 281.1 were from MEHP and D4-labeled
MEHP, respectively.
Product ion profiles of the probable metabolite II
(m/z 291.1, 28.1 min) and IV (m/z 293.1, 29.0 min) were
Figure 3. LC-MS data of an incubated sample with DEHP and
D4-DEHP (5:5) plotted from the (a) raw peak list of MES and (b)
IPs, containing probable metabolite signals, mined by SMAIT
analysis in the group with five concentration ratios.compared with those of their corresponding commer-cial standards (Table 2). The two probable metabolites
(II and IV) were identified as 5OH-MEHP and 5oxo-
MEHP, respectively. The precursor ions and product
ion profiles of metabolite III were very similar to those
of the 5oxo-MEHP standard. Furthermore, the small RT
difference between the 5oxo-MEHP standard and me-
tabolite III shows that metabolite III was an oxo-MEHP
isomer. Precursor ions and product ion profiles of
metabolites V, VI, and VII were very similar to those of
the 5OH-MEHP standard. The small RT difference led
us to believe that these are part of the five OH-MEHP
isomers. Additionally, for metabolites V, VI, and VII,
we also observed 4-Da shifts of precursor ions and
product ions between native and stable isotope-labeled
compounds. Therefore, metabolites V, VI, and VII were
identified as the three isomers of OH-MEHPs.
Product ion profiles of the four probable metabolite
signals of m/z 345.1 (VIII) and 361.1 (IX, X, XI) contained
product ions at m/z 277.1 and 293.1. Furthermore, the
product ions of their isotopic probable metabolites, at
m/z 345.1 and 361.1, contained 4-Da shift signals, m/z
277.1 to 281.1, and m/z 293.1 to 297.1, respectively. This
4-Da shift of product ions demonstrated that the prob-
able metabolites contained benzene and D4-labeled ben-
zene groups. Additionally, the 148 Da mass difference
between precursor (m/z 345) and product (m/z 197) ions
indicated primarily the loss of phthalic anhydride. A
similar mass difference of 148 Da was observed with
ions from m/z 293 to 145. Data indicated that the
metabolite VIII could be generated and modified at the
side-chain of DEHP via in vitro liver enzyme incuba-
tion. The metabolites XII, XIII, XIV, and XV also showed
a mass difference of 148 Da. This corresponds to a loss
of the phthalic anhydride from DEHP, between the
precursor and product ions. Data demonstrated that
these metabolites should be modified at the side-chain
of DEHP via in vitro liver enzyme incubation. We also
considered that these metabolites were DEHP-derived.
The confirmed metabolites were compared with re-
ported metabolites in the literature [9–11]. According to
the DEHP metabolic pathway, DEHP is oxidized to
yield MEHP, a mono-ester, in the first stage. Subse-
quently, MEHP is further metabolized to generate five
Table 1. DEHP metabolite signals recognized by SMAIT










m/z 277.1 (281.1) 34.1 0.956 1
m/z 291.1 (295.1) 28.0 0.993 2
m/z 293.1 (297.1) 28.9 0.997 3
m/z 293.1 (297.1) 29.9 0.991 1
m/z 345.1 (349.1) 34.1 0.985 1
m/z 361.1 (365.1) 28.9 0.995 3
m/z 397.1 (401.1) 34.1 0.965 1
m/z 409.1 (413.1) 28.9 0.995 3aTotal number of peaks present in both XICs.
238 LIN ET AL. J Am Soc Mass Spectrom 2010, 21, 232–241Figure 4. Extract ion chromatograms of the probable metabolite signals mined via the SMAIT
strategy in a sample with DEHP and D4-DEHP (5:5). These IPs contained (a) m/z 277.1 and 288.1, (b)
m/z 291.1, and 295.1, (c) m/z 293.1 and 297.1, (d) m/z 345.1 and 349.1, (e) m/z 361.1 and 365.1, (f) m/z
397.1 and 401.1, and (g) m/z 409.1 and 413.1.
tive
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the second stage. The hydroxyl metabolites can be
oxidized to generate oxo-metabolites. For the DEHP
metabolism pathway, secondary metabolites coming
from the primary metabolite (MEHP) were reported
for five OH-MEHP isomers having different hydroxyl
group binding positions. In results, seven metabolite
signals, MEHP, four OH-MEHP isomers, and two oxo-
MEHP isomers, were confirmed by commercial stan-
dards. The four OH-MEHP isomers were recognized,
although only one metabolite (5OH-MEHP) could be
confirmed by a commercial standard. In the third st-
age of DEHP metabolism, two oxo-MEHP isomers were
observed. The 5oxo-MEHP showed a higher response
compared with the other oxo-MEHP isomer. Similar
results have been reported [9]. Other reported metabo-
lites that were not recognized by the SMAIT program
may be the result of metabolite signal intensities that
were too low to be detected by LC-MS.
Recently, LC-MS instrumentation with high sensitiv-
ity, selectivity, and productivity has shown its useful-
















II 28.1 291.1 120.9248 (66)
143.1285 (100)
IId 28.0 295.1 125.0553 (100)
143.1046 (97)
III 28.3 291.1 120.9358 (50)
143.0033 (100)
IIId 28.2 295.1 124.9691 (30)
143.0034 (100)
IV 29.0 293.1 121.0497 (83)
145.1455 (100)
IVd 29.0 297.1 125.0742 (67)
145.1455 (100)
V 29.2 293.1 121.0335 (20)
145.1345 (100)
Vd 29.1 297.1 125.0732 (47)
145.1450 (100)
VI 29.3 293.1 121.0450 (21)
145.1457 (100)
VId 29.2 297.1 125.0715 (11)
145.1462 (100)
VII 30.1 293.1 121.0401 (13)
145.1435 (100)
VIId 30.0 297.1 124.9714 (17)
145.1447 (100)
*The top four intensive product ions are shown. The proportion of relaness in the development of metabolite identificationstrategies [14–17]. Several LC-MS-coupled strategies,
such as the radio isotope-labeling technology [18–23],
metabolite prediction strategy [15, 15], exact mass filter
strategy [24–26], and signal tracing by particular isoto-
pic ratio strategy [6], have been reported for the assis-
tance of metabolite identification. It is considered that
radio isotope-labeling technology is a golden method
for metabolite ID, but it has several advantages, includ-
ing the associated health hazards and waste disposal
issues. The metabolite prediction strategy has been
utilized to predict metabolic routes that a parent com-
pound will likely undergo. This method then specifi-
cally looks for mass changes between the parent com-
pound and its metabolites to confirm the prediction.
However, this strategy relies on previous knowledge of
the metabolic pathways. Meanwhile, the exact mass
filtering strategy uses mass defects as a specific filter.
This is based on the exact mass and mass deficiencies
specific to each parent drug of interest. The strategy can
help to remove unwanted peaks in LC-MS data and
dramatically reduce the number of potential metabolite











xo-MEHP 28.0 291.1 121.0310 (70)
143.1062 (100)
H-MEHP 28.6 293.1 121.0263 (66)
145.1173 (100)





240 LIN ET AL. J Am Soc Mass Spectrom 2010, 21, 232–241Isotope-labeling method coupled with LC-MS anal-
ysis provides a route to trace compound-derived me-
tabolite signals. As for SMAIT, the calculation of the
correlation coefficient among five different ratios and
their responses, rather than only one ratio, are carried
out to enhance the compound-derived ion detection
efficiency. SMAIT is currently available through the
website located at http://binfo.csie.ncku.edu.tw:8080/
SMAIT/. Noise removal, baseline correction, and peak
detection procedures should be accomplished by other
peak-picking software (e.g., MES) before SMAIT pro-
gram. The input data structure of SMAIT is a *.txt file
with three columns, peak m/z, retention time and re-
sponse. (As illustrated in Supporting Information A,
which can be found in the electronic version of this
article).
Additionally, another approach was suggested that
uses the direct point out method (e.g., radio-isotope
tracer and stable isotope tracer) combined with the
exact mass filter strategy. This could also increase the
accuracy of metabolite detection [17].
Conclusions
In the present study, the proposed statistical procedure
could enhance the efficiency and confidence of detect-
ing compound-derived signals in LC-MS data. A com-
putational program (SMAIT) was developed to execute
the data processing and statistical analysis. However,
the procedure has not yet been applied to an in vivo
experiment. Signal levels within in vivo matrices are
often low and masked by endogenous signals, which
may result in peak loss. Besides, in vivo experiments
with this strategy may be costly, laborious, and time-
prohibitive for five different ratios used. Thus, further
work should be carried out to investigate the applica-
bility and the flexibility of this strategy to in vivo
experiments. Additionally, the procedure was limited
Table 3. Product ion profiles of DEHP structurally-related meta

















*Intense product ions are shown. The proportion of relative abundancby the artificial isotopes, which prohibit its utility inmining fixed ratio natural isotopes, such as Cl, Br,
etc. [6].
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